These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6197332)

  • 1. Effects of proglumide on pancreatic acinar cell function.
    Williams JA; Bailey A; Steigerwalt RW
    Digestion; 1983; 27(4):227-33. PubMed ID: 6197332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proglumide (gastrin and cholecystokinin receptor antagonist) inhibits insulin secretion in vitro.
    Verspohl EJ; Wunderle G; Ammon HP; Williams JA; Goldfine ID
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):284-7. PubMed ID: 3012373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New proglumide-analogue CCK receptor antagonists: very potent and selective for peripheral tissues.
    Niederau C; Niederau M; Williams JA; Grendell JH
    Am J Physiol; 1986 Jun; 250(6 Pt 1):G856-60. PubMed ID: 2424321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo effect of proglumide on cholecystokinin-stimulated amylase release in mouse pancreatic acini.
    Iwamoto Y; Nakamura R; Akanuma Y
    Gastroenterol Jpn; 1984 Feb; 19(1):53-8. PubMed ID: 6202584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural features of various proglumide-related cholecystokinin receptor antagonists.
    Jensen RT; Zhou ZC; Murphy RB; Jones SW; Setnikar I; Rovati LA; Gardner JD
    Am J Physiol; 1986 Dec; 251(6 Pt 1):G839-46. PubMed ID: 2431626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
    Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat.
    Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Digestion; 1989; 42(2):61-9. PubMed ID: 2475379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proglumide analogues: potent cholecystokinin receptor antagonists.
    Jensen RT; Murphy RB; Trampota M; Schneider LH; Jones SW; Howard JM; Gardner JD
    Am J Physiol; 1985 Aug; 249(2 Pt 1):G214-20. PubMed ID: 2411147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CR-1409: a potent inhibitor of cholecystokinin-stimulated amylase release and cholecystokinin binding in rat pancreatic acini.
    Iwamoto Y; Yamamoto R; Kuzuya T
    Pancreas; 1987; 2(1):85-90. PubMed ID: 2437574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of three different cholecystokinin receptor antagonists on basal and stimulated insulin and glucagon secretion in mice.
    Karlsson S; Ahrén B
    Acta Physiol Scand; 1989 Mar; 135(3):271-8. PubMed ID: 2648765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proglumide analogues CR 1409 and CR 1392 inhibit cholecystokinin-stimulated insulin release more potently than exocrine secretion from the isolated perfused rat pancreas.
    Okabayashi Y; Otsuki M; Nakamura T; Fujii M; Tani S; Fujisawa T; Koide M; Hasegawa H; Baba S
    Pancreas; 1990 May; 5(3):291-7. PubMed ID: 2188254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibitory effect of a new proglumide derivative, loxiglumide, on CCK action in isolated rat pancreatic acini].
    Fujii M; Otsuki M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):77-82. PubMed ID: 2471851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proglumide and benzotript: members of a different class of cholecystokinin receptor antagonists.
    Hahne WF; Jensen RT; Lemp GF; Gardner JD
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6304-8. PubMed ID: 6171817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of proglumide on ductal and basolateral secretion of pancreatic digestive enzymes.
    Niederau C; Grendell JH; Rothman SS
    Am J Physiol; 1985 Jul; 249(1 Pt 1):G100-7. PubMed ID: 2409815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of proglumide on cholecystokinin-8-induced exocrine and endocrine pancreatic responses in conscious sheep.
    Mineo H; Iwaki N; Kogishi K; Onaga T; Kato S; Zabielski R
    Comp Biochem Physiol A Physiol; 1997 Nov; 118(3):759-64. PubMed ID: 9406447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asperlicin: a unique nonpeptide cholecystokinin antagonist.
    Zucker KA; Adrian TE; Zdon MJ; Ballantyne GH; Modlin IM
    Surgery; 1987 Aug; 102(2):163-70. PubMed ID: 2441481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies.
    Louie DS; Liang JP; Owyang C
    Am J Physiol; 1988 Sep; 255(3 Pt 1):G261-6. PubMed ID: 2458681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of cholecystokinin receptor binding to regulation of biological functions in pancreatic acini.
    Sankaran H; Goldfine ID; Bailey A; Licko V; Williams JA
    Am J Physiol; 1982 Mar; 242(3):G250-7. PubMed ID: 6175228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of proglumide on pancreatic endocrine and exocrine function in healthy humans.
    Funakoshi A; Nakano I; Shinozaki H; Miyazaki K; Ibayashi H
    Regul Pept; 1987 Jun; 17(6):311-8. PubMed ID: 3299507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lorglumide and loxiglumide inhibit gastrin-stimulated DNA synthesis in a rat tumoral acinar pancreatic cell line (AR42J).
    Seva C; Scemama JL; Bastié MJ; Pradayrol L; Vaysse N
    Cancer Res; 1990 Sep; 50(18):5829-33. PubMed ID: 2393852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.